Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
International Journal of Molecular Sciences|August 12, 2022
Tailoring the Structure of Cell Penetrating DNA and RNA Binding NucleopeptidesStefano Tomassi, Caterina Ieranò, Alessandra Del Bene, et al.
Journal of Experimental & Clinical Cancer Research : CR|December 6, 2018
Mutated Von Hippel-Lindau-renal cell carcinoma (RCC) promotes patients specific natural killer (NK) cytotoxicityAnna Maria Trotta, Sara Santagata, Serena Zanotta, et al.
Scientific Reports|October 5, 2018
Photosystem-II D1 protein mutants of Chlamydomonas reinhardtii in relation to metabolic rewiring and remodelling of H-bond network at Q<sub>B</sub> siteAmina Antonacci, Maya D Lambreva, Andrea Margonelli, et al.
Hepatology International|May 4, 2023
Hepatocellular carcinoma (HCC) tumor microenvironment is more suppressive than colorectal cancer liver metastasis (CRLM) tumor microenvironmentSara Santagata, Giuseppina Rea, Daniela Castaldo, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|July 1, 2020
Disulfide Bond Replacement with 1,4- and 1,5-Disubstituted [1,2,3]-Triazole on C-X-C Chemokine Receptor Type 4 (CXCR4) Peptide Ligands: Small Changes that Make Big DifferencesStefano Tomassi, Anna Maria Trotta, Caterina Ieranò, et al.
Bioorganic & Medicinal Chemistry|April 17, 2018
Cationic nucleopeptides as novel non-covalent carriers for the delivery of peptide nucleic acid (PNA) and RNA oligomersStefano Tomassi, Caterina Ieranò, Maria Emilia Mercurio, et al.
Pharmacological Research|November 4, 2022
Enhanced efficacy of formoterol-montelukast salt in relieving asthma features and in preserving β2-agonists rescue therapyIda Cerqua, Elisabetta Granato, Antonio Petti, et al.
Cell Death & Disease|July 24, 2019
CXCL12 loaded-dermal filler captures CXCR4 expressing melanoma circulating tumor cellsCaterina Ieranò, Crescenzo D'Alterio, Simona Giarra, et al.
Journal of Experimental & Clinical Cancer Research : CR|October 30, 2019
Targeting CXCR4 potentiates anti-PD-1 efficacy modifying the tumor microenvironment and inhibiting neoplastic PD-1Crescenzo D'Alterio, Maria Buoncervello, Caterina Ieranò, et al.
Cancers|July 26, 2020
New CXCR4 Antagonist Peptide R (Pep R) Improves Standard Therapy in Colorectal CancerCrescenzo D'Alterio, Antonella Zannetti, Anna Maria Trotta, et al.
Pageof 6